Ono Pharmaceutical Co. Ltd. stock is traded under the ticker #4528. Below you can review Ono Pharmaceutical Co. Ltd. stock performance in the past 12 months up to June 2026

Total visits to Ono Pharmaceutical Co. Ltd.'s top domains

Understand Ono Pharmaceutical Co. Ltd. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ono.co.jp1.6K

See more with Sales Intelligence

Avg. visit duration in Ono Pharmaceutical Co. Ltd.'s top domains

Analyze Ono Pharmaceutical Co. Ltd. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ono.co.jp00:00:10

See more with Sales Intelligence

Avg. pageviews on Ono Pharmaceutical Co. Ltd.'s top domains

See how Ono Pharmaceutical Co. Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ono.co.jp1.39

See more with Sales Intelligence

Ono Pharmaceutical Co. Ltd. top competitors by domain

Top similar sites in June 2026, ranked by their affinity

novartis.co.jpCompany NameNovartisEmployees> 10001HQSwitzerland, BaselAnnual revenue> $1BTotal visits81.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Ono Pharmaceutical Co. Ltd.

These are the website technologies, by industry, used by Ono Pharmaceutical Co. Ltd. top domains

Email Services (5)

G Suite

Audio Video Media (3)

YouTube

Advertising (2)

DoubleClick

Content Management System (2)

Drupal

More Technologies

5

See all

News & Signals from Ono Pharmaceutical Co. Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOno partners with KSQ Therapeutics, Inc..Japan-headquartered Ono Pharmaceutical has entered an agreement with US-based KSQ Therapeutics, a clinical-stage biotechnology company developing therapies to treat cancer and autoimmune diseases, to aquire multiple research-stage DNA damage response (DDR) programmes identified using KSQ’s proprietary, integrated discovery CRISPRomics platform technology.